Tirzepatide

Tirzepatide is a research peptide being studied for its potential effects on glucose metabolism and weight regulation. It functions as a dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, which are involved in insulin secretion and appetite control. Currently, Tirzepatide is for research purposes only and is not approved for human consumption or medical use outside of authorized clinical studies.